Fabry Disease: New Diagnosis of a Family

Authors

DOI:

https://doi.org/10.24950/CC/268/20/1/2021

Keywords:

alpha-Galactosidase, Fabry Disease, Rare Diseases

Abstract

Fabry’s disease is a rare inherited disease, linked to the X chromosome, that results from a deficiency of alfa‐galactosidase A activity. We report the case of a 59-year-old -man admitted in the emergency department after a fall herald by chest pain. Cardiac ultrasound showed exuberant left ventricle hypertrophy and complementary study with cardiac magnetic resonance showed intramyocardial fibrosis. The rest of the study also showed a proteinuria of 2.15 g/24 hours. Past medical history highlighted an ischemic stroke at 50 years- -old and vasospastic angina at 52 years-old. He also reported many years of symptoms compatible with acroparesthesias and had angiokeratomas since childhood. Suspecting Fabry’s disease, we measured the blood levels of alpha-galactosidase A, which showed a severe reduction in enzyme activity, confirming the diagnosis. Genetic study showed the p.G35E mutation in the alpha-galactosidase gene in our patient, his three daughters and one grandchild.

Downloads

Download data is not yet available.

References

Winchester B, Young E. Biochemical and genetic diagnosis of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 18.

Weidemann F, Sanchez-Niño MD, Politei J, Oliveira JP, Wanner C, Warnock D, et al. Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis. 2013;8:116. doi: 10.1186/1750-1172-8-116.

Perretta F, Antongiovanni N, Jaurretche S. Major Organic Involvement in Women with Fabry Disease in Argentina. ScientificWorldJournal. 2018;2018:6515613. doi: 10.1155/2018/6515613.

Juchniewicz P, Kloska A, Tylki-Szymanska A, Jakóbkiewicz-Banecka J, Wegrzyn G, Moskot M, et al. Female Fabry disease patients and X-chromosome inactivation. Gene. 2018;641:259-64. doi: 10.1016/j.gene.2017.10.064.

Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, et al.F abry disease the New Great Imposter: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet. 2012;81:571-7. doi: 10.1111/j.1399-0004.2011.01718.x.

Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, et al. Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. J Am Soc Nephrol. 2017;28:1631-41. doi: 10.1681/ASN.2016090964.

Akpinar ÇK, Türker H, Bayrak O, Cengiz N. Electroneuromyographic Features in Fabry Disease: A Retrospective Review. Noro Psikiyatr Ars. 2015;52:258-62. doi: 10.5152/npa.2015.7646.

Ínan R, Mese M, Bicik Z. Multidisciplinary approach to Fabry disease: from the eye of a neurologist. Acta Neurol Belg. 2020;120:1333-9. doi: 10.1007/s13760-019-01138-y.

Yagita Y, Sakai N, Miwa K, Ohara N, Tanaka M, Sakaguchi M, et al. Magnetic Resonance Imaging Findings Related to Stroke Risk in Japanese Patients With Fabry Disease. Stroke. 2019;50:2571-3. doi: 10.1161/STROKEAHA.119.025528.

Vardarli I, Rischpler C, Herrmann K, Weidemann F. Diagnosis and Screening of Patients with Fabry Disease. Ther Clin Risk Manag. 2020;16:551-8. doi: 10.2147/TCRM.S247814.

Linhart A, Germain DP, Olivotto I, Akhtar MM, Anastasakis A, Hughes D, et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020;22:1076-96. doi: 10.1002/ejhf.1960.

Kitani Y, Nakagawa N, Sakamoto N, Takeuchi T, Takahashi F, Momosaki K, et al. Unexpectedly High Prevalence of Coronary Spastic Angina in Patients With Anderson-Fabry Disease. Circ J. 2019;83:481-4. doi: 10.1253/circj.CJ-18-0734.

Cho SC, Yoo HW, Lee JW, Jang JY, Heo R, Song JM. Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation. J Cardiovasc Ultrasound. 2016;24:324-8. doi:10.4250/jcu.2016.24.4.324.

Waldek S, Feriozzi S. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?. BMC Nephrol. 2014;15:72. doi: 10.1186/1471-2369-15-72.

van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis. 2020;43:908-21. doi: 10.1002/jimd.12228.

Published

2021-09-20

How to Cite

1.
Sousa D, Gonçalves B, Bayão A. Fabry Disease: New Diagnosis of a Family. RPMI [Internet]. 2021 Sep. 20 [cited 2024 Dec. 18];28(1):35-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/84

Issue

Section

Case Reports